{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:56:11Z","timestamp":1781657771021,"version":"3.54.5"},"reference-count":30,"publisher":"Norwegian Medical Association","issue":"12\/13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2012,6,26]]},"DOI":"10.4045\/tidsskr.12.0542","type":"journal-article","created":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T11:51:51Z","timestamp":1341489111000},"page":"1476-8","source":"Crossref","is-referenced-by-count":0,"title":["HPV-testing \u2013 svak begrunnelse for kontroversiell beslutning"],"prefix":"10.4045","volume":"132","author":[{"given":"Ivar S\u00f8nb\u00f8","family":"Kristiansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","unstructured":"Kreftregisteret. Masseunders\u00f8kelsen mot livmorhalskreft. www.kreftregisteret.no\/no\/Forebyggende\/Masseundersokelsen-mot-livmorhalskreft (15.5.2012)."},{"key":"ref=2","unstructured":"Nilsen L. Vil fjerne refusjonstaksten for HPV-test. Dagens Medisin 2010; nr. 11: 4."},{"key":"ref=3","unstructured":"Rindahl Endresen MJ, Andreassen T. Revidering og presisering av cervixscreeningprogrammet \u2013 H\u00f8ring (brev av 11.2. 2011 fra Helsedirektoratet). Oslo: Helsedirektoratet, 2011."},{"key":"ref=4","unstructured":"Haldorsen T, Skare GB, Bj\u00f8rge T. Sekund\u00e6rscreening med HPV-tester i\u00a0Masseunders\u00f8kelsen mot livmorhalskreft. Oslo: Kreftregisteret, 2011."},{"key":"ref=5","unstructured":"Rindahl Endresen MJ, Andreassen T. Vurdering av HPV-tester med hensyn p\u00e5 kravene i Masseunders\u00f8kelsen mot livmorhalskreft (brev av 20.12. 2011 Helsedirektoratet). Oslo: Helsedirektoratet, 2011."},{"key":"ref=6","unstructured":"Skriftlig sp\u00f8rsm\u00e5l fra Per Arne Olsen (FrP) til helse- og omsorgsministeren. www.stortinget.no\/no\/Saker-og-publikasjoner\/Sporsmal\/Skriftlige-sporsmal-og-svar\/Skriftlig-sporsmal\/?qid=52351 (15.5.2012)."},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Sargent A, Bailey A, Almonte M et al. Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br J Cancer 2008; 98: 1704\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18392052&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038\/sj.bjc.6604324","DOI":"10.1038\/sj.bjc.6604324"},{"key":"ref=8","unstructured":"Cancer in Norway 2009. Oslo: Kreftregisteret, 2011."},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Kristiansen IS. Hva er evidensbaserte r\u00e5d? Tidsskr Nor Legeforen 2012; 132: 638-9. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22456143&dopt=Abstract","DOI":"10.4045\/tidsskr.12.0269"},{"key":"ref=10","unstructured":"Johansen BK, Skare GB, Haldorsen T et al. \u00c5rsrapport 2008. Masseunders\u00f8kelser mot livmorhalskreft. Oslo: Kreftregisteret, 2009."},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Korfage IJ, van Ballegooijen M, Huveneers H et al. Anxiety and borderline PAP smear results. Eur J Cancer 2010; 46: 134\u2009\u2013\u200941. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19683428&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.ejca.2009.07.003","DOI":"10.1016\/j.ejca.2009.07.003"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Bruinsma FJ, Quinn MA. The risk of preterm birth following treatment for precancerous changes in the cervix: a systematic review and meta-analysis. BJOG 2011; 118: 1031\u2009\u2013\u200941. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21449928&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1471-0528.2011.02944.x","DOI":"10.1111\/j.1471-0528.2011.02944.x"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Albrechtsen S, Rasmussen S, Thoresen S et al. Pregnancy outcome in women before and after cervical conisation: population based cohort study. BMJ 2008; 337: a1343. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18801869&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136\/bmj.a1343","DOI":"10.1136\/bmj.a1343"},{"key":"ref=14","unstructured":"Kreftregisteret. Cellepr\u00f8ven. http:\/\/kreftregisteret.no\/no\/Forebyggende\/Masseundersokelsen-mot-livmorhalskreft\/Celleproven\/ (18.5.2012)."},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Burger EA, Korn\u00f8r H, Klemp M et al. HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review. Gynecol Oncol 2011; 120: 430\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21130490&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.ygyno.2010.11.013","DOI":"10.1016\/j.ygyno.2010.11.013"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342\u2009\u2013\u200950. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12044010&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038\/nrc798","DOI":"10.1038\/nrc798"},{"key":"ref=17","unstructured":"ASCUS-LSIL Traige Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003; 188: 1383\u2009\u2013\u200992. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12824967&dopt=Abstract"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Castle PE. The evolving definition of carcinogenic human papillomavirus. Infect Agent Cancer 2009; 4: 7. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19432962&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1186\/1750-9378-4-7","DOI":"10.1186\/1750-9378-4-7"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Meijer CJ, Berkhof J, Castle PE et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 2009; 124: 516\u2009\u2013\u200920. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18973271&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002\/ijc.24010","DOI":"10.1002\/ijc.24010"},{"key":"ref=20","unstructured":"Kreftregisteret. Regnestykke p\u00e5 sensitivitet. www.kreftregisteret.no\/no\/Generelt\/Nyheter\/Regnestykket-pa-sensitivitet\/ (3.4.2012)."},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Tinacci G, Biggeri A, Pellegrini A et al. The use of digital images to evaluate the interobserver agreement on cervical smear readings in Italian cervical cancer screening. Cytopathology 2011; 22: 75\u2009\u2013\u200981. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20482719&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1365-2303.2010.00753.x","DOI":"10.1111\/j.1365-2303.2010.00753.x"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Elsheikh TM, Kirkpatrick JL, Fischer D et al. Does the time of day or weekday affect screening accuracy? A pilot correlation study with cytotechnologist workload and abnormal rate detection using the ThinPrep Imaging System. Cancer Cytopathol 2010; 118: 41\u2009\u2013\u20096. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20099317&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002\/cncy.20060","DOI":"10.1002\/cncy.20060"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001; 285: 1500\u2009\u2013\u20095. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11255427&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1001\/jama.285.11.1500","DOI":"10.1001\/jama.285.11.1500"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Massad LS, Jeronimo J, Katki HA et al. The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia. J Low Genit Tract Dis 2009; 13: 137\u2009\u2013\u200944. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19550210&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/LGT.0b013e31819308d4","DOI":"10.1097\/LGT.0b013e31819308d4"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"Zuchna C, Hager M, Tringler B et al. Diagnostic accuracy of guided cervical biopsies: a prospective multicenter study comparing the histopathology of simultaneous biopsy and cone specimen. Am J Obstet Gynecol 2010; 203: 321. e1\u2009\u2013\u20096. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20633870&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.ajog.2010.05.033","DOI":"10.1016\/j.ajog.2010.05.033"},{"key":"ref=26","doi-asserted-by":"crossref","unstructured":"Ost\u00f6r AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12: 186\u2009\u2013\u200992. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8463044&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/00004347-199304000-00018","DOI":"10.1097\/00004347-199304000-00018"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"McCredie MR, Sharples KJ, Paul C et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008; 9: 425\u2009\u2013\u200934. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18407790&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S1470-2045(08)70103-7","DOI":"10.1016\/S1470-2045(08)70103-7"},{"key":"ref=28","unstructured":"Bakke KA. Kreftalarm: Gynekologer krever granskning. Dagens Medisin 2012; nr. 4."},{"key":"ref=29","unstructured":"Equity and excellence: liberating the NHS. London: Department of Health, 2010."},{"key":"ref=30","doi-asserted-by":"crossref","unstructured":"Burger EA, Ortendahl JD, Sy S et al. Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway. Br J Cancer 2012; 106: 1571\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22441643&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038\/bjc.2012.94","DOI":"10.1038\/bjc.2012.94"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:44:59Z","timestamp":1781657099000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2012\/06\/kronikk\/hpv-testing-svak-begrunnelse-kontroversiell-beslutning"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,26]]},"references-count":30,"journal-issue":{"issue":"12\/13","published-print":{"date-parts":[[2012,6,26]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.12.0542","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,26]]}}}